trimetazidine has been researched along with phosphocreatine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Lavanchy, N; Martin, J; Rossi, A | 2 |
Aussedat, J; Harpey, C; Kay, L; Ray, A; Rossi, A; Verdys, M | 1 |
Calori, G; De Cobelli, F; Del Maschio, A; Esposito, A; Fragasso, G; Lattuada, G; Margonato, A; Palloshi, A; Perseghin, G; Scifo, P | 1 |
Bian, YY; Cao, KJ; Chen, XJ; Feng, L; Li, P; Meng, D; Yang, D; Zhang, JN | 1 |
Allaart, CP; Bakermans, AJ; Bronzwaer, PNA; de Man, FS; Geurkink, KTJ; Handoko, ML; Kok, WEM; Nederveen, AJ; Oosterveer, FTP; van de Bovenkamp, AA; van Rossum, AC | 1 |
2 trial(s) available for trimetazidine and phosphocreatine
Article | Year |
---|---|
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
Topics: Adenosine Triphosphate; Aged; Cross-Over Studies; Double-Blind Method; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Magnetic Resonance Angiography; Male; Phosphocreatine; Prospective Studies; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross-over trial.
Topics: Adenosine Triphosphate; Aged; Cross-Over Studies; Female; Heart Failure; Humans; Male; Phosphocreatine; Stroke Volume; Trimetazidine | 2023 |
4 other study(ies) available for trimetazidine and phosphocreatine
Article | Year |
---|---|
[Trimetazidine preservation of the energy potential of the myocardium during ischemia and reperfusion. Phosphorus NMR spectroscopy study of the isolated heart].
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Female; Hydrogen-Ion Concentration; In Vitro Techniques; Magnetic Resonance Spectroscopy; Phosphocreatine; Phosphorylation; Piperazines; Rats; Rats, Inbred Strains; Trimetazidine | 1986 |
Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart.
Topics: Adenosine Triphosphate; Animals; Coronary Disease; Energy Metabolism; Female; Magnetic Resonance Spectroscopy; Myocardium; Phosphates; Phosphocreatine; Phosphorylation; Piperazines; Rats; Rats, Inbred Strains; Trimetazidine | 1987 |
Improvement of long-term preservation of isolated arrested rat heart: beneficial effect of the antiischemic agent trimetazidine.
Topics: Adenosine Triphosphate; Animals; Cardioplegic Solutions; Coronary Circulation; Female; Glycogen; Heart; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Myocardium; Organ Preservation; Phosphocreatine; Rats; Rats, Wistar; Trimetazidine; Ventricular Function, Left | 1993 |
Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats.
Topics: Adenosine Triphosphate; Animals; Astragalus propinquus; Calcium; Cardiotonic Agents; Drugs, Chinese Herbal; Heart Injuries; Injections, Subcutaneous; Isoproterenol; Male; Myocardium; Myocytes, Cardiac; Phosphocreatine; Random Allocation; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents | 2006 |